Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study

Virtually no clinical trials for smoking cessation have been undertaken in bipolar disorder. Varenicline has shown efficacy for smoking cessation, but warnings about neuropsychiatric adverse events have been issued. We assessed the efficacy and safety of varenicline in euthymic bipolar subjects moti...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The journal of clinical psychiatry Ročník 75; číslo 7; s. 765
Hlavní autori:	Chengappa, K N Roy, Perkins, Kenneth A, Brar, Jaspreet S, Schlicht, Patricia J, Turkin, Scott R, Hetrick, Michelle L, Levine, Michele D, George, Tony P
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.07.2014
Predmet:	Adult Benzazepines - administration & dosage Benzazepines - adverse effects Benzazepines - pharmacology Bipolar Disorder - drug therapy Bipolar Disorder - epidemiology Comorbidity Double-Blind Method Female Humans Male Middle Aged Nicotinic Agonists - administration & dosage Nicotinic Agonists - adverse effects Nicotinic Agonists - pharmacology Quinoxalines - administration & dosage Quinoxalines - adverse effects Quinoxalines - pharmacology Smoking - drug therapy Smoking - epidemiology Smoking Cessation - methods Treatment Outcome Varenicline
ISSN:	1555-2101, 1555-2101
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!